Scot Holman, MD
Ophthalmology · Tavares, FLNPI 1467533505
Payments from drug & device makers
Across 237 payments — averaging $84.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$15K
- Nova Eye, Inc.$1K
- Ocular Therapeutix, Inc.$799
- Sight Sciences, Inc.$759
- AbbVie$737
- Alcon$538
- plus $1K from 17 others
What the payments were for
- Consulting fees$4,48222%
- Speaking & faculty fees$8,02640%
- Travel & lodging$6323%
- Food & beverage$5,39127%
- Gifts$450%
- Entertainment$1,2976%
- Other$1501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 36 | $14,550 |
| Nova Eye, Inc. | 2 | $1,436 |
| Ocular Therapeutix, Inc. | 38 | $799 |
| Sight Sciences, Inc. | 30 | $759 |
| AbbVie(2 entities) | 45 | $737 |
| Alcon | 30 | $538 |
| Novartis | 11 | $236 |
| Rxsight Inc | 7 | $220 |
| Biotissue Holdings Inc. | 6 | $121 |
| Rayner Intraocular Lenses Limited | 5 | $102 |
| Glaukos Corporation | 3 | $90 |
| Ivantis, Inc | 4 | $84 |
| Aerie Pharmaceuticals, Inc. | 4 | $65 |
| NEW World Medical,inc. | 3 | $54 |
| Bausch & Lomb Americas Inc. | 2 | $39 |
| Oyster Point Pharma, Inc. | 2 | $35 |
| Omeros Corporation | 2 | $34 |
| Shire North American Group Inc | 2 | $34 |
| Dompe US, Inc. | 1 | $21 |
| Beaver-visitec International, Inc. | 1 | $21 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Eyepoint US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Multifocal Family of 1-piece IOLS$5,768
- Catalys Laser System$5,666
- Tecnis 1-piece IOL$4,316
- Tecnis 3-piece IOL$4,316
- Tecnis iTec Preloaded Delivery System$4,316
- Tecnis Symfony IOL$2,258
- Whitestar Phacoemulsficiation System$1,350
- OMNI(R) SURGICAL SYSTEM (US)$373
- Tecnis IOL$140
- Clareon PanOptix Pro$121
- RXSIGHT CONTACT LENS$118
- RXSIGHT INJECTOR CARTRIDGE$118
- RXSIGHT INJECTOR HANDPIECE$118
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$118
- LIGHT ADJUSTABLE LENS (LAL)$118
- Tecnis Simplicity$110
- CATALYS SYSTEM$110
How this compares
$20,023 in reported general payments places this provider in the 85th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 99 | $142,805 |
| XiidraLifitegrast | 86 | $109,944 |
| Cyclosporine | 39 | $25,656 |
| LumiganBimatoprost | 32 | $23,005 |
| Prednisolone Acetate | 309 | $10,129 |
| Timolol Maleate | 97 | $4,848 |
| Brimonidine Tartrate | 68 | $4,689 |
| Latanoprost | 354 | $4,043 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 15 | $3,028 |
| Loteprednol Etabonate | 19 | $2,671 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $2,652 |
| Fluorometholone | 18 | $1,933 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 134 | $1,693 |
| Acetazolamide | 20 | $670 |
| ErythromycinErythromycin Base | 39 | $403 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan | $737 | $165,810131 claims |
| Bausch & Lomb Americas Inc.Xiidra | $39 | $109,94486 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $19 | $2,67119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,405 ophthalmology providers in Florida.
Other ophthalmology in Tavares
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
- Cathleen McCabeBradenton$4.6M
- Ivan SunerTampa$3.7M
- Sunir JoshiFt Lauderdale$3.7M
- Harold BrooksTallahassee$3.5M
- Matthew CunninghamOrlando$2.9M
- Benjamin ThomasJacksonville$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.